Tirzepatide has become an important prescription treatment option for people managing type 2 diabetes or exploring medically supervised weight management. But before starting treatment, one question comes up frequently: How much does tirzepatide cost, and will insurance cover it?
The answer depends on the medication prescribed, your insurance benefits, the dosage, and where you obtain your prescription. Manufacturer savings programs can also make a significant difference.
In 2026, eligible patients can access certain FDA-approved Zepbound self-pay options starting at $299 for a 28-day supply. Patients with qualifying commercial insurance and manufacturer savings may pay as little as $25, while others may face substantially higher costs.
At Drip Lounge, our tirzepatide program currently advertises a starting price of $395, with clinical assessment and ongoing provider oversight described on the service page. Patients should confirm exactly what that starting price covers, the billing period, medication availability, and whether additional fees apply.
This guide breaks down the actual costs to consider, how insurance coverage works, and what to ask before committing to treatment.
How Much Does Tirzepatide Cost in 2026?
Tirzepatide is the active ingredient in two FDA-approved prescription medications:
- Zepbound: Approved for chronic weight management in eligible adults and for certain adults with obesity and moderate-to-severe obstructive sleep apnea.
- Mounjaro: Approved for management of type 2 diabetes, with additional approved indications reflected in its current prescribing information.
Although both contain tirzepatide, they have different approved uses and may have different insurance coverage rules.
Tirzepatide Price Comparison: With and Without Insurance
| Treatment or payment option | Advertised cost | Important details |
|---|---|---|
| Zepbound self-pay, 2.5 mg | Starting at $299 per 28-day supply | Manufacturer program; terms apply |
| Zepbound self-pay, 5 mg | Starting at $399 per 28-day supply | Manufacturer program; terms apply |
| Zepbound self-pay, 7.5–15 mg | Starting at $449 per 28-day supply | Higher-dose promotional pricing subject to refill timing and eligibility |
| Mounjaro self-pay | Starting at $499 per month | LillyDirect pricing; eligibility and terms apply |
| Zepbound with qualifying commercial insurance | As low as $25 with eligible savings | Not available to everyone; actual costs depend on coverage |
| Zepbound through Medicare GLP-1 Bridge | $50 monthly copayment | Available only to qualifying beneficiaries for the covered product |
| Drip Lounge tirzepatide program | Desde $395 | Confirm billing period, inclusions, medication formulation, and availability |
Prices checked October 22, 2026. Manufacturer prices are subject to change. The quoted amounts do not necessarily include consultation fees, supplies, laboratory testing, taxes, or other services. Drip Lounge's advertised starting price is not directly comparable with manufacturer medication-only prices until the included services and billing period are confirmed.
Sources: LillyDirect Zepbound, LillyDirect Mounjaro, and Medicare coverage information.
How Much Does Tirzepatide Cost Without Insurance?
If you do not have insurance, or your policy excludes the prescribed medication, you may have to pay out of pocket.
The good news is that the retail list price is not necessarily what every uninsured patient must pay. Manufacturer self-pay programs can provide more predictable pricing for eligible patients.
Zepbound Cost Without Insurance
Eli Lilly offers self-pay options for Zepbound through LillyDirect and participating pharmacy channels.
As of October 2026, advertised starting prices include:
- 2.5 mg: $299 per 28-day supply.
- 5 mg: $399 per 28-day supply.
- 7.5 mg to 15 mg: $449 per 28-day supply under applicable promotional terms.
For higher doses, maintaining the promotional price generally requires purchasing the next refill within 45 days of receiving the previous prescription. Missing that window can result in a higher price, with regular prices reaching $699 for some doses and delivery devices.
These prices require a valid prescription and satisfaction of the applicable program conditions. Additional supplies or fees may apply.
The lowest advertised price is also not necessarily your long-term price. The 2.5 mg Zepbound dose is intended for treatment initiation rather than maintenance, so costs may change as treatment progresses.
Mounjaro Cost Without Insurance
Mounjaro also contains tirzepatide, but it is prescribed under its own FDA-approved indications, including type 2 diabetes.
LillyDirect currently advertises Mounjaro self-pay options starting at $499 per month across listed strengths, subject to the manufacturer's terms.
Patients should not assume that a Mounjaro prescription will qualify for the same pricing, savings programs, or insurance benefits as Zepbound.
Are There Lower-Cost Tirzepatide Programs?
Some healthcare providers advertise weight-management programs with lower starting prices than traditional retail pharmacy charges.
However, an advertised program price may cover different services or a different medication formulation. It may not represent the same FDA-approved product sold under the Zepbound or Mounjaro brand names.
This distinction is particularly important for compounded tirzepatide.
Compounded medications are not FDA-approved, and their safety, effectiveness, and quality have not undergone the same FDA premarket review as approved products. Federal law also restricts routine compounding of medications that are essentially copies of commercially available FDA-approved drugs.
Because FDA determined that the tirzepatide shortage had been resolved, broad shortage-based exceptions to those restrictions are no longer in effect. Whether a specific compounded prescription may lawfully be prepared depends on the facts and applicable compounding requirements.
Before accepting a quoted price, ask which exact medication is being supplied, whether it is FDA-approved, and how its regulatory and clinical status differs from branded tirzepatide.
Read the FDA's guidance on compounded GLP-1 medications.
How Much Does Tirzepatide Cost With Insurance?
Insurance can substantially reduce the cost of tirzepatide, but coverage is not automatic.
Your out-of-pocket expense will depend on several factors:
- Whether the prescribed brand is included in your plan's drug formulary.
- Whether the medication is prescribed for an approved, covered indication.
- Your deductible, copayment, or coinsurance.
- Any prior authorization or other utilization requirements.
- Whether you qualify for manufacturer savings.
For some commercially insured patients, eligible savings programs can reduce the cost of an approved branded prescription to as little as $25.
However, this is a conditional promotional price, not a universal insurance copay.
Does Insurance Cover Tirzepatide for Weight Loss?
Some private insurance plans cover Zepbound for eligible patients, while others exclude medications prescribed specifically for weight management.
A plan may also require documentation of clinical eligibility, previous treatment history, or participation in a comprehensive weight-management program.
The most reliable way to determine coverage is to check your plan's current formulary and request a patient-specific cost estimate.
When contacting your insurer, ask:
- Is Zepbound covered under my prescription drug benefits?
- Is prior authorization required?
- What medical criteria must I meet?
- What is my estimated cost at the prescribed dose?
- Does the cost change after meeting my deductible?
- Which pharmacies are in network?
For people exploring treatment options, Drip Lounge provides information about medically supervised weight-management services, including different prescription-based approaches.
Does Medicare Cover Tirzepatide in 2026?
Medicare coverage changed significantly in July 2026.
Beginning July 1, 2026, the temporary Medicare GLP-1 Bridge program expanded access to certain weight-management medications for qualifying Medicare Part D beneficiaries.
The program includes Zepbound KwikPen, with a $50 monthly copayment for eligible participants.
However, the program does not cover every Zepbound delivery device, and eligibility is limited.
For example, qualifying criteria include specific combinations of body mass index (BMI) and medical conditions. Some beneficiaries with type 2 diabetes, moderate-to-severe sleep apnea, or fatty liver disease are excluded from the Bridge program because their Medicare drug plans may provide access through separate coverage pathways.
The $50 Bridge copayment does not count toward the standard Medicare Part D deductible or yearly out-of-pocket limit.
Patients should check their eligibility directly through Medicare's official GLP-1 coverage guide.
Important: Medicare Bridge coverage applies to specified FDA-approved medications, not to compounded tirzepatide or any medication offered by an individual clinic simply because it contains the same active ingredient.
